Decision
Clarify the scientific, operational, or business decision the AI workflow is meant to support.
SignalForge Advisors
Life-sciences AI/data advisory for decision-ready R&D workflows.
AI Consulting for Pharma, Biotech & Life Sciences
Before you scale AI, know what you can trust.
SignalForge helps life-sciences teams identify which AI use cases are ready, which workflows are fragile, and which evidence gaps need to be fixed before larger investment.
We start with the decision, the workflow, the data-generating process, the assumptions, and the risk. Then we help define the first pilot worth testing.
The problem
AI adoption in life sciences rarely fails because teams lack ambition. It fails because the decision context is unclear, the workflow is fragile, the data provenance is incomplete, or the pilot is chosen before the evidence environment is understood.
Leaders are under pressure to move quickly. Vendors are pitching platforms. Teams are experimenting with LLMs, copilots, internal tools, and analytics workflows. But the central question often remains unanswered.
Which decisions and workflows are actually ready for AI support?
Why SignalForge starts earlier
Model-first AI is the wrong starting point for evidence-heavy work. Before a team builds, buys, or scales, it needs to understand what the workflow is trying to accomplish and whether the underlying evidence can support the intended decision.
SignalForge works before the build decision. We help teams determine what is ready for AI, what needs repair, what should remain human-led, and which pilot is worth testing first.
The output is not an AI vision deck. It is a practical decision artifact: what to pursue, what to avoid, what to fix first, and what to test next.
Common AI pain points
If you are a CEO, CIO, AI strategy leader, R&D leader, or digital transformation lead, the hard part is rarely deciding whether AI matters. The hard part is deciding where AI can create value without creating new scientific, operational, or governance risk.
SignalForge helps life-sciences teams turn AI pressure into clearer decisions, safer pilots, and stronger operating edge.
| What leaders are experiencing | What is really at stake | SignalForge Engagement | SignalForge Method | Advisory Fee | Expected Edge |
|---|---|---|---|---|---|
| The CEO wants an AI strategy, but the organization is not aligned on where AI should create value. | Strategic credibility. Leadership needs momentum without funding vague transformation work or chasing tool demos. | Scan | Identify decision-critical workflows, map candidate use cases, assess evidence readiness, and separate practical AI opportunities from distraction. | Focused fixed fee | A sharper AI agenda, faster executive alignment, and a defensible first move. |
| The CIO or digital leader is being asked to support AI adoption, but the business has not defined workflow, risk, or success criteria. | Implementation risk. Technology teams may inherit poorly scoped experiments that are hard to govern, scale, or defend. | Scan to Pilot | Translate business ambition into workflow requirements, review points, data dependencies, governance needs, and pilot-ready criteria. | Fixed fee, then scope-based | Cleaner handoff between business, science, data, IT, and vendor teams. |
| AI strategy planners are surrounded by ideas, but every function wants something different. | Prioritization risk. Without a shared decision framework, the roadmap becomes disconnected experiments. | Scan | Score use cases by decision value, workflow readiness, data quality, human review needs, risk, feasibility, and time-to-signal. | Focused fixed fee | A portfolio view of AI opportunities with clear sequencing and rationale. |
| R&D teams have valuable historical data, but no one is sure whether it is reusable, trustworthy, or AI-ready. | Evidence risk. Poor provenance, weak metadata, hidden bias, or inconsistent experimental context can make outputs look more reliable than they are. | Scan | Review data-generating process, provenance, metadata, completeness, drift, assumptions, limitations, and decision relevance. | Focused fixed fee | Clearer understanding of what can be trusted, repaired, reused, or excluded. |
| A vendor claims their AI platform can accelerate discovery, evidence synthesis, regulatory work, or decision support. | Buying risk. The organization needs to know whether the claim holds up against its data, workflows, scientific context, and operating constraints. | Scan | Test vendor claims against workflow fit, evidence requirements, validation needs, user behavior, data access, and failure modes. | Focused fixed fee | Better buy, pause, narrow, negotiate, or reject decisions before larger spend. |
| A document-heavy workflow is slowing medical, regulatory, scientific, commercial, or R&D teams. | Operating leverage. Senior time is consumed by synthesis, review, drafting, comparison, and handoff work. | Pilot | Map the workflow, identify repeatable steps, design an AI-assisted process, define review gates, and test against real constraints. | Scope-based project fee | Faster synthesis, cleaner review, less manual drag, and stronger human oversight. |
| The organization wants to prove AI value without launching a broad transformation program. | Political and budget risk. A poorly scoped pilot can damage confidence, while a well-scoped pilot can create momentum. | Pilot | Define one bounded workflow, success criteria, review gates, limitations, evaluation plan, and scale decision memo. | Scope-based project fee | A concrete go, revise, scale, or stop decision based on evidence rather than enthusiasm. |
| AI usage is already happening informally across teams, but leadership lacks visibility into risk, quality, and consistency. | Governance risk. Shadow AI adoption can create uneven quality, unclear accountability, data exposure, and inconsistent outputs. | Scan to Run | Identify current usage patterns, define review points, create lightweight guardrails, and establish recurring advisory review where needed. | Fixed fee to monthly advisory | Better control without slowing useful experimentation. |
| Scientific, data, IT, and business stakeholders are talking past each other. | Translation risk. AI work stalls when teams cannot connect scientific nuance, data reality, technical feasibility, and executive decisions. | Scan or Run | Build shared decision artifacts, clarify assumptions, define roles, document risks, and translate technical findings into executive-ready recommendations. | Fixed fee to monthly advisory | Faster cross-functional decisions and fewer stalled initiatives. |
| AI/data workflows are expanding and the team needs senior judgment across roadmap, vendors, risks, and execution. | Continuity risk. Teams need experienced review without necessarily adding another full-time internal function. | Run | Provide recurring advisory cadence, roadmap steering, technical review memos, vendor scrutiny, workflow hardening, and decision support. | Monthly advisory, scope-dependent | More consistent decisions, faster escalation, less fragility, and better operating cadence. |
Fee bands are directional and intentionally high level. Final scope depends on data access, workflow complexity, stakeholder availability, technical depth, urgency, and whether the work is a Scan, Pilot, or ongoing Run engagement.
AI Readiness Scan
A first-principles diagnostic before you buy, build, or scale.
The AI Readiness Scan gives your team a structured view of where AI can create value, where the foundation is not ready, what risks need to be managed, and which workflow should be tested first.
Evidence
Inspect data, metadata, provenance, assumptions, uncertainty, context, and scientific constraints.
Workflow
Map the current process, handoffs, review points, manual work, bottlenecks, and failure modes.
Pilot
Identify one bounded AI/data workflow worth testing with clear success criteria and human review.
What you get
The Scan is designed to produce concrete decision support, not generic AI strategy language.
- AI opportunity map for relevant scientific, operational, and knowledge workflows
- Evidence environment review covering data quality, provenance, assumptions, gaps, and decision relevance
- Workflow map showing where AI could assist, where humans must remain in control, and where risk enters
- Use-case prioritization based on value, feasibility, readiness, uncertainty, and risk
- Recommended first pilot with scope, success criteria, review gates, and implementation considerations
- Executive-ready summary of what to pursue, what to avoid, what to fix first, and what to test next
Where SignalForge helps
We focus on evidence-heavy workflows where AI can support better synthesis, faster review, cleaner handoffs, and more defensible decisions.
- Scientific evidence synthesis and literature review workflows
- R&D decision-support workflows
- Omics and bioinformatics workflow review
- Historical data readiness and reuse
- Vendor and AI-tool evaluation
- LLM-assisted research, drafting, and review workflows with human checkpoints
- Medical, regulatory, scientific, and commercial document workflows
- Internal knowledge management for scientific and technical teams
- Executive-ready decision memos for AI pilot selection
Common triggers
SignalForge is usually brought in when a life-sciences team knows AI matters but does not yet have a defensible implementation path.
- Leadership wants an AI roadmap, but the right first use case is unclear
- Teams are experimenting with AI tools without a shared governance or review model
- Scientific data exists, but provenance, metadata, quality, or reuse potential is uncertain
- A vendor or platform claim needs technical and scientific scrutiny
- A document-heavy workflow is slowing research, regulatory, medical, or commercial work
- A team wants to test an AI workflow without overcommitting to a large transformation program
Best fit
SignalForge is a strong fit for pharma, biotech, diagnostics, medtech, CROs, life-sciences services firms, and health-tech organizations evaluating where AI can responsibly help.
The best-fit teams are usually facing unclear AI use cases, underused scientific data, fragmented workflows, vendor claims that need scrutiny, repetitive document work, complex evidence synthesis, or pressure from leadership to move faster without creating avoidable risk.
Science first. Data quality second. AI only where the evidence supports it.
What SignalForge is not
SignalForge is not a generic chatbot shop, a clinical decision automation vendor, a replacement for QA, or a vehicle for unvalidated AI claims.
We do not start by forcing AI into a workflow. We start by understanding the work, the evidence, the decision, and the constraints. If AI is not the right answer, the recommendation should say so.
Next step
If your team is asking where AI fits, what to pilot first, or whether your data and workflows are ready, start with a Scan.
You will leave with a clearer view of the opportunity, the risks, the workflow, and the next practical move.